NCT02022306View on ClinicalTrials.gov

TD-6450 SAD and MAD in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Hepatitis C
Interventions
DRUG

TD-6450

DRUG

Placebo

Trial Locations (1)

78209

ICON Development Solutions, San Antonio

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY